Skip to main content
Blog

Excessive Blood Sugar – Symptoms, Causes and Treatment

Felix Weber

Felix Weber

2026-03-20
5 min. read
Excessive Blood Sugar – Symptoms, Causes and Treatment

Excessive Blood Sugar – Symptoms, Causes and Treatment

55 views
Excessive blood sugar, also known as hyperglycemia, refers to a high level of glucose in the blood. After consuming a meal, particularly one rich in carbohydrates, glucose appears in the blood, leading to the production of insulin by the pancreas. This hormone plays a critical role in regulating blood sugar levels by transporting glucose from the bloodstream to the cells of our body. If insulin is not properly secreted or its action is not effective, this can result in elevated blood sugar levels, known as hyperglycemia.

Elevated blood glucose concentration (hyperglycemia)

Hyperglycemia represents a pathological condition characterized by blood glucose concentrations that significantly exceed established physiological norms [1]. In healthy individuals, fasting blood glucose levels typically range between 72–99 mg/dL (equivalent to 4.0–5.5 mmol/L). This condition may manifest either in a fasting state or following meal consumption (postprandial hyperglycemia). Fasting hyperglycemia is identified when plasma glucose exceeds 100 mg/dL. Values up to 125 mg/dL are classified as impaired fasting glucose, whereas surpassing this threshold warrants a diagnosis of diabetes mellitus. Postprandial hyperglycemia is diagnosed when blood glucose levels exceed 140 mg/dL at the 120-minute mark after eating. If the concentration remains below 199 mg/dL, impaired glucose tolerance is recognized, while higher values indicate diabetes [2].

Elevated blood glucose concentrations – clinical manifestations and hallmark symptoms

An elevated concentration of glucose in blood plasma manifests through a constellation of clinically significant symptoms, including: persistent and excessive thirst (polydipsia), markedly increased urinary frequency (polyuria), progressive opacification of the ocular lens accompanied by diminished visual acuity, relentless fatigue of metabolic origin, and compromised immune defense against infectious agents—resulting in heightened susceptibility to infections characterized by prolonged, treatment-resistant courses [1]. Additional manifestations comprise excessive dryness of the epidermis, episodic nausea, and a detectable odor of ketone bodies in exhaled breath resembling acetone. In severe, untreated cases of hyperglycemia, the condition may progress to ketoacidosis, potentially culminating in diabetic coma [4].

Hyperglycemia is the cause

In people who do not have diabetes, regular blood sugar levels may lead to hyperglycemia. Eating too many meals, eating too many carbohydrates, or using certain medicines. Hyperglycaemia may also be caused by infections and inflammation that increase insulin demand. In patients with diabetes, it is extremely important to regularly check their blood sugar level.

Comprehensive hyperglycemia management: Evidence-based approaches to glycemic control and prevention of metabolic complications

The management of hyperglycemia necessitates a multifaceted approach that integrates pharmacological interventions with behavioral modifications to achieve optimal glycemic control. Beyond the immediate reduction of elevated blood glucose levels through carefully selected antidiabetic medications, therapeutic success depends on maintaining adequate hydration, implementing a personalized nutritional plan, and incorporating structured physical activity. Weight reduction represents another critical component, as it enhances tissue sensitivity to insulin. Complementary support may be derived from natural compounds with documented hypoglycemic properties, including cinnamon extract (which demonstrates modulatory effects on carbohydrate metabolism), fenugreek seeds, and the polyphenols found in green tea. In the context of type 2 diabetes mellitus—where hyperglycemia serves as a primary risk factor for microvascular and macrovascular complications—a comprehensive treatment strategy must address both insulin resistance and impaired β-cell secretory function. Pharmacological options may include oral hypoglycemic agents (e.g., sulfonylureas that stimulate insulin secretion), insulin sensitizers (such as metformin), DPP-4 inhibitors that prolong incretin activity, and GLP-1 receptor agonists that delay gastric emptying. Severe hyperglycemic episodes may require intravenous administration of rapid-acting insulin. Uncontrolled or inadequately managed hyperglycemia accelerates the progression of obesity, exacerbates type 2 diabetes, and elevates cardiovascular risk. Early diagnosis, consistent glucose monitoring, and collaborative care with a multidisciplinary diabetes team are therefore essential to tailor individualized treatment regimens that mitigate long-term metabolic complications.
Felix Weber

Felix Weber

View Profile

Scan this QR code to access this page quickly on your mobile device.

QR Code